1. Home
  2. CYTK vs WFRD Comparison

CYTK vs WFRD Comparison

Compare CYTK & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • WFRD
  • Stock Information
  • Founded
  • CYTK 1997
  • WFRD 1941
  • Country
  • CYTK United States
  • WFRD United States
  • Employees
  • CYTK N/A
  • WFRD N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • WFRD Metal Fabrications
  • Sector
  • CYTK Health Care
  • WFRD Industrials
  • Exchange
  • CYTK Nasdaq
  • WFRD Nasdaq
  • Market Cap
  • CYTK 5.0B
  • WFRD 5.2B
  • IPO Year
  • CYTK 2004
  • WFRD N/A
  • Fundamental
  • Price
  • CYTK $50.26
  • WFRD $65.48
  • Analyst Decision
  • CYTK Strong Buy
  • WFRD Strong Buy
  • Analyst Count
  • CYTK 17
  • WFRD 9
  • Target Price
  • CYTK $82.00
  • WFRD $122.44
  • AVG Volume (30 Days)
  • CYTK 1.9M
  • WFRD 1.5M
  • Earning Date
  • CYTK 02-27-2025
  • WFRD 02-05-2025
  • Dividend Yield
  • CYTK N/A
  • WFRD 1.14%
  • EPS Growth
  • CYTK N/A
  • WFRD 19.26
  • EPS
  • CYTK N/A
  • WFRD 6.75
  • Revenue
  • CYTK $3,219,000.00
  • WFRD $5,513,000,000.00
  • Revenue This Year
  • CYTK N/A
  • WFRD $0.13
  • Revenue Next Year
  • CYTK $754.18
  • WFRD $4.38
  • P/E Ratio
  • CYTK N/A
  • WFRD $9.76
  • Revenue Growth
  • CYTK N/A
  • WFRD 7.36
  • 52 Week Low
  • CYTK $40.53
  • WFRD $60.45
  • 52 Week High
  • CYTK $81.36
  • WFRD $135.00
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 58.40
  • WFRD 41.69
  • Support Level
  • CYTK $45.05
  • WFRD $65.92
  • Resistance Level
  • CYTK $48.30
  • WFRD $74.33
  • Average True Range (ATR)
  • CYTK 2.80
  • WFRD 3.33
  • MACD
  • CYTK 0.61
  • WFRD 0.41
  • Stochastic Oscillator
  • CYTK 86.80
  • WFRD 36.24

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About WFRD Weatherford International plc

Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.

Share on Social Networks: